Nektar Therapeutics
$16.759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$16.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (0.06%) Today
-$0.24 (-1.41%) As of 6:29 PM EDT after-hours
Why Robinhood?
You can buy or sell NKTR and other stocks, options, ETFs, and crypto commission-free!
About NKTR
Nektar Therapeutics Common Stock, also called Nektar Therapeutics, is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. Read More It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.
Employees
618
Headquarters
San Francisco, California
Founded
1990
Market Cap
2.98B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
4.24M
High Today
$17.28
Low Today
$16.58
Open Price
$16.92
Volume
3.74M
52 Week High
$69.76
52 Week Low
$16.56
Collections
NKTR News
Price Paid on Robinhood
62% Lower
Right Now
52 Week Low
$29.22
Average Price Paid
$43.60
52 Week High
$92.17
Analyst Ratings
79%
of 14 ratings
Buy
79%
Hold
21%
Sell
0%
NKTR Earnings
-$0.80
$1.24
$3.29
$5.33
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 7, After Hours
